Literature DB >> 14499459

Disorders of cochlear blood flow.

Tsutomu Nakashima1, Shinji Naganawa, Michihiko Sone, Mitsuo Tominaga, Hideo Hayashi, Hiroshi Yamamoto, Xiuli Liu, Alfred L Nuttall.   

Abstract

The cochlea is principally supplied from the inner ear artery (labyrinthine artery), which is usually a branch of the anterior inferior cerebellar artery. Cochlear blood flow is a function of cochlear perfusion pressure, which is calculated as the difference between mean arterial blood pressure and inner ear fluid pressure. Many otologic disorders such as noise-induced hearing loss, endolymphatic hydrops and presbycusis are suspected of being related to alterations in cochlear blood flow. However, the human cochlea is not easily accessible for investigation because this delicate sensory organ is hidden deep in the temporal bone. In patients with sensorineural hearing loss, magnetic resonance imaging, laser-Doppler flowmetry and ultrasonography have been used to investigate the status of cochlear blood flow. There have been many reports of hearing loss that were considered to be caused by blood flow disturbance in the cochlea. However, direct evidence of blood flow disturbance in the cochlea is still lacking in most of the cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499459     DOI: 10.1016/s0165-0173(03)00189-9

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  62 in total

1.  [Rheopheresis as a successful second-line treatment for sudden hearing loss].

Authors:  M Canis; M Suckfüll
Journal:  HNO       Date:  2010-05       Impact factor: 1.284

Review 2.  [Possible molecular mechanisms of spontaneous remission in sudden idiopathic hearing loss].

Authors:  U-R Heinrich; J Brieger; R H Stauber; W J Mann
Journal:  HNO       Date:  2011-11       Impact factor: 1.284

3.  Immunocytochemical distribution of WARP (von Willebrand A domain-related protein) in the inner ear.

Authors:  Trac Duong; Ivan A Lopez; Akira Ishiyama; Gail Ishiyama
Journal:  Brain Res       Date:  2010-11-18       Impact factor: 3.252

4.  In vivo imaging of mammalian cochlear blood flow using fluorescence microendoscopy.

Authors:  Ashkan Monfared; Nikolas H Blevins; Eunice L M Cheung; Juergen C Jung; Gerald Popelka; Mark J Schnitzer
Journal:  Otol Neurotol       Date:  2006-02       Impact factor: 2.311

5.  Relationship between CT densitometry with a slice thickness of 0.5 mm and audiometry in otosclerosis.

Authors:  Setsuko Kawase; Shinji Naganawa; Michihiko Sone; Mitsuru Ikeda; Takeo Ishigaki
Journal:  Eur Radiol       Date:  2006-03-11       Impact factor: 5.315

6.  Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma.

Authors:  Masahiro Yamazaki; Shinji Naganawa; Hisashi Kawai; Takashi Nihashi; Hiroshi Fukatsu; Tsutomu Nakashima
Journal:  Neuroradiology       Date:  2009-12       Impact factor: 2.804

7.  Role of cysteinyl leukotriene signaling in a mouse model of noise-induced cochlear injury.

Authors:  Jung-Sub Park; Seo-Jun Kang; Mi-Kyoung Seo; Ilo Jou; Hyun Goo Woo; Sang Myun Park
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

8.  Infliximab has no apparent effect in the inner ear hearing function of patients with rheumatoid arthritis and ankylosing spondylitis.

Authors:  H Toktas; E Okur; U Dundar; A Dikici; O K Kahveci
Journal:  Clin Rheumatol       Date:  2014-04-27       Impact factor: 2.980

9.  A Surgical Procedure for the Administration of Drugs to the Inner Ear in a Non-Human Primate Common Marmoset (Callithrix jacchus).

Authors:  Sho Kurihara; Masato Fujioka; Tomohiko Yoshida; Makoto Koizumi; Kaoru Ogawa; Hiromi Kojima; Hirotaka James Okano
Journal:  J Vis Exp       Date:  2018-02-27       Impact factor: 1.355

10.  Effects of hypoxia on cochlear blood flow in mice evaluated using Doppler optical microangiography.

Authors:  Suzan Dziennis; Roberto Reif; Zhongwei Zhi; Alfred L Nuttall; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2012-10       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.